Ryan F. Quarles: “It is not our intention. Indeed, it is the opposite of our intention, to affect the total loss-absorbing capacity of the…”

Similarly, that has always been a high priority of the Federal Reserve, and where we have the enforcement authority to act, we will do that.

The FDA needs to provide regulatory pathways for products containing CBD. The FDA needs to act now.

I think that you can actually have more effect in really supporting the low- and moderate-income portions of the communities.

I don't think that we should be weakening the CRA.